-
s Small Molecule Allosteric Activators of Human Glucokinase for the Treatment of Type 2 Diabetes: Current Status and Challenges
- Source: Current Drug Discovery Technologies, Volume 19, Issue 4, Jul 2022, p. 1 - 3
-
- 01 Jul 2022
- Previous Article
- Table of Contents
- Next Article
Preview this article:




Small Molecule Allosteric Activators of Human Glucokinase for the Treatment of Type 2 Diabetes: Current Status and Challenges, Page 1 of 1
< Previous page Next page > /docserver/preview/fulltext/cddt/19/4/s1-1.gif
There is no abstract available.
© Bentham Science Publishers